$1.90
-0.09[-4.52%]
At close: Apr 26
$1.90
0[0.00%]
After Hours: 7:49PM EDT
Esperion Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Esperion Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/07/2024 | AM | ESPR | Q1 | -$0.79 | $0.05 | — | — | $24.33M | $84.51M | — | — | Get Alert |
02/27/2024 | AM | ESPR | Q4 | -$0.76 | -$0.48 | -$0.50 | -4.17% | $18.82M | $28.70M | $32.25M | 12.37% | Get Alert |
11/07/2023 | AM | ESPR | Q3 | -$0.81 | -$0.43 | -$0.37 | 13.95% | $18.98M | $29.58M | $33.97M | 14.84% | Get Alert |
08/01/2023 | AM | ESPR | Q2 | -$1.05 | -$0.63 | -$0.46 | 26.98% | $18.84M | $25.50M | $25.79M | 1.12% | Get Alert |
05/09/2023 | AM | ESPR | Q1 | -$0.93 | -$0.65 | -$0.79 | -21.54% | $18.84M | $22.01M | $24.33M | 10.54% | Get Alert |
02/21/2023 | AM | ESPR | Q4 | -$1.77 | -$0.84 | -$0.76 | 9.52% | $15.40M | $20.85M | $18.82M | -9.75% | Get Alert |
11/01/2022 | AM | ESPR | Q3 | -$2.62 | -$0.93 | -$0.81 | 12.90% | $14.41M | $19.74M | $18.98M | -3.85% | Get Alert |
08/02/2022 | AM | ESPR | Q2 | -$1.67 | -$0.93 | -$1.05 | -12.90% | $40.66M | $18.71M | $18.84M | 0.70% | Get Alert |
05/03/2022 | AM | ESPR | Q1 | -$3.50 | -$1.04 | -$0.93 | 10.58% | $7.98M | $15.39M | $18.84M | 22.39% | Get Alert |
02/22/2022 | AM | ESPR | Q4 | -$3.89 | -$2.27 | -$1.77 | 22.03% | $9.64M | $14.47M | $15.40M | 6.43% | Get Alert |
11/02/2021 | AM | ESPR | Q3 | -$3.07 | -$2.79 | -$2.62 | 6.09% | $3.83M | $12.85M | $14.41M | 12.13% | Get Alert |
08/03/2021 | AM | ESPR | Q2 | $4.32 | -$1.84 | -$1.67 | 9.24% | $212.24M | $42.27M | $40.66M | -3.81% | Get Alert |
05/04/2021 | PM | ESPR | Q1 | -$2.84 | -$2.52 | -$3.50 | -38.89% | $1.84M | $26.12M | $7.98M | -69.46% | Get Alert |
02/23/2021 | PM | ESPR | Q4 | -$2.26 | -$3.76 | -$3.89 | -3.46% | $982.00K | $12.52M | $9.64M | -23.02% | Get Alert |
11/02/2020 | PM | ESPR | Q3 | -$2.52 | -$3.41 | -$3.07 | 9.97% | $981.00K | $5.93M | $3.83M | -35.36% | Get Alert |
08/10/2020 | PM | ESPR | Q2 | -$2.01 | $1.71 | $4.32 | 152.63% | $982.00K | $147.97M | $212.24M | 43.43% | Get Alert |
05/06/2020 | PM | ESPR | Q1 | $3.07 | -$3.29 | -$2.84 | 13.68% | $145.42M | $520.00K | $1.84M | 253.85% | Get Alert |
02/27/2020 | PM | ESPR | Q4 | -$2.24 | -$2.67 | -$2.26 | 15.36% | $0.00 | — | $982.00K | — | Get Alert |
11/06/2019 | AM | ESPR | Q3 | -$1.86 | -$1.95 | -$2.52 | -29.23% | $0.00 | $900.00K | $981.00K | 9.00% | Get Alert |
Esperion Therapeutics (ESPR) is scheduled to report earnings on May 7, 2024. The last reported earnings were for reported on February 27, 2024 for Q4.
The Actual EPS was $-0.50, which missed the estimate of $-0.48.
The Actual Revenue was $32.3M, which beat the estimate of $28.7M.
Browse earnings estimates, EPS, and revenue on all stocks.